261 related articles for article (PubMed ID: 17179229)
1. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.
Coupel S; Moreau A; Hamidou M; Horejsi V; Soulillou JP; Charreau B
Blood; 2007 Apr; 109(7):2806-14. PubMed ID: 17179229
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.
Nattermann J; Nischalke HD; Hofmeister V; Kupfer B; Ahlenstiel G; Feldmann G; Rockstroh J; Weiss EH; Sauerbruch T; Spengler U
Antivir Ther; 2005; 10(1):95-107. PubMed ID: 15751767
[TBL] [Abstract][Full Text] [Related]
3. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
4. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
6. Natural killer clones recognize specific soluble HLA class I molecules.
Carbone E; Terrazzano G; Colonna M; Tuosto L; Piccolella E; Franksson L; Palazzolo G; Pérez-Villar JJ; Fontana S; Kärre K; Zappacosta S
Eur J Immunol; 1996 Mar; 26(3):683-9. PubMed ID: 8605938
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis.
Wooden SL; Kalb SR; Cotter RJ; Soloski MJ
J Immunol; 2005 Aug; 175(3):1383-7. PubMed ID: 16034073
[TBL] [Abstract][Full Text] [Related]
8. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
9. The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.
Sala FG; Del Moral PM; Pizzato N; Legrand-Abravanel F; Le Bouteiller P; Lenfant F
Immunogenetics; 2004 Dec; 56(9):617-24. PubMed ID: 15578261
[TBL] [Abstract][Full Text] [Related]
10. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
[TBL] [Abstract][Full Text] [Related]
11. Irradiation-induced up-regulation of HLA-E on macrovascular endothelial cells confers protection against killing by activated natural killer cells.
Riederer I; Sievert W; Eissner G; Molls M; Multhoff G
PLoS One; 2010 Dec; 5(12):e15339. PubMed ID: 21179573
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
14. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells.
Fons P; Chabot S; Cartwright JE; Lenfant F; L'Faqihi F; Giustiniani J; Herault JP; Gueguen G; Bono F; Savi P; Aguerre-Girr M; Fournel S; Malecaze F; Bensussan A; Plouët J; Le Bouteiller P
Blood; 2006 Oct; 108(8):2608-15. PubMed ID: 16809620
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
Malmberg KJ; Levitsky V; Norell H; de Matos CT; Carlsten M; Schedvins K; Rabbani H; Moretta A; Söderström K; Levitskaya J; Kiessling R
J Clin Invest; 2002 Nov; 110(10):1515-23. PubMed ID: 12438449
[TBL] [Abstract][Full Text] [Related]
17. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
[TBL] [Abstract][Full Text] [Related]
20. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
